Oncogenic MUC1-C promotes tamoxifen resistance in human breast cancer.
about
Metabolomic profiling of hormone-dependent cancers: a bird's eye viewIntracellular Targeting of the Oncogenic MUC1-C Protein with a Novel GO-203 Nanoparticle FormulationTargeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells.Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomas.MUC1-C Induces the LIN28B→LET-7→HMGA2 Axis to Regulate Self-Renewal in NSCLCCtr9, a key subunit of PAFc, affects global estrogen signaling and drives ERα-positive breast tumorigenesis.MUC1-C Stabilizes MCL-1 in the Oxidative Stress Response of Triple-Negative Breast Cancer Cells to BCL-2 Inhibitors.MUC1-C nuclear localization drives invasiveness of renal cancer cells through a sheddase/gamma secretase dependent pathway.BASP1 interacts with oestrogen receptor α and modifies the tamoxifen response.MUC5AC interactions with integrin β4 enhances the migration of lung cancer cells through FAK signaling.MUC1 induces tamoxifen resistance in estrogen receptor-positive breast cancer.Inverse association of rab31 and mucin-1 (CA15-3) antigen levels in estrogen receptor-positive (ER+) breast cancer tissues with clinicopathological parameters and patients' prognosis.MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells.Mucin 1 promotes radioresistance in hepatocellular carcinoma cells through activation of JAK2/STAT3 signaling.Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer
P2860
Q28084834-CB116849-8EA7-4656-8D2A-BCE4EB0AE34BQ28394194-4F6A7654-51E1-405C-9820-A64BA648FFB8Q33757061-58250EF2-598E-406E-8A57-71B15157057EQ34914935-B0160C3B-D655-42BD-B431-E8F58ABCA700Q35204592-E5572BE3-74C1-4028-9EAC-09F7C576A1C8Q36199639-986FF328-59AC-4AA2-8CF1-3DD969586126Q36928457-0FE67C75-B6D5-46E8-880F-767D8F9D0134Q37718458-8AD4D98B-2AA9-417D-864B-18CA62F9C46BQ38792891-A11774CC-C5D6-45F3-AC3A-814338C0C53EQ38804960-615A05B5-8ED7-49A9-A550-B64809EE9EC7Q39361672-F5133268-8F21-4CCB-8764-7A3A29E55324Q41890324-94D9A880-9439-4FA3-86F4-6503FE19035FQ48146766-8419B90F-0821-42DD-8EED-F7F6C3FE8ABDQ49300596-FA1C3E6E-FCEA-4624-BBC3-9E6D0926D25AQ57107973-1C5AC3BD-A293-4776-AA8B-9096279543BB
P2860
Oncogenic MUC1-C promotes tamoxifen resistance in human breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oncogenic MUC1-C promotes tamoxifen resistance in human breast cancer.
@en
Oncogenic MUC1-C promotes tamoxifen resistance in human breast cancer.
@nl
type
label
Oncogenic MUC1-C promotes tamoxifen resistance in human breast cancer.
@en
Oncogenic MUC1-C promotes tamoxifen resistance in human breast cancer.
@nl
prefLabel
Oncogenic MUC1-C promotes tamoxifen resistance in human breast cancer.
@en
Oncogenic MUC1-C promotes tamoxifen resistance in human breast cancer.
@nl
P2093
P2860
P1476
Oncogenic MUC1-C promotes tamoxifen resistance in human breast cancer.
@en
P2093
Akriti Kharbanda
Caining Jin
Deepak Raina
Donald Kufe
Hasan Rajabi
P2860
P304
P356
10.1158/1541-7786.MCR-12-0668
P577
2013-03-28T00:00:00Z